{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:56:27Z","timestamp":1774302987323,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-024-01322-2","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T06:07:46Z","timestamp":1737698866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["V3+ extends the V3 framework to ensure user-centricity and scalability of sensor-based digital health technologies"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-4747","authenticated-orcid":false,"given":"Jessie P.","family":"Bakker","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9762-4769","authenticated-orcid":false,"given":"Roland","family":"Barge","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6691-7923","authenticated-orcid":false,"given":"Jacob","family":"Centra","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-8720","authenticated-orcid":false,"given":"Bryan","family":"Cobb","sequence":"additional","affiliation":[]},{"given":"Chas","family":"Cota","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1530-0172","authenticated-orcid":false,"given":"Christine C.","family":"Guo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-2379","authenticated-orcid":false,"given":"Bert","family":"Hartog","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7593-9869","authenticated-orcid":false,"given":"Nathalie","family":"Horowicz-Mehler","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7150-1748","authenticated-orcid":false,"given":"Elena S.","family":"Izmailova","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-1400","authenticated-orcid":false,"given":"Nikolay V.","family":"Manyakov","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-9700","authenticated-orcid":false,"given":"Samantha","family":"McClenahan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0416-6461","authenticated-orcid":false,"given":"St\u00e9phane","family":"Motola","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-0430","authenticated-orcid":false,"given":"Smit","family":"Patel","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1418-5850","authenticated-orcid":false,"given":"Oana","family":"Paun","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-5506","authenticated-orcid":false,"given":"Marian","family":"Schoone","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8798-9605","authenticated-orcid":false,"given":"Emre","family":"Sezgin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4998-6453","authenticated-orcid":false,"given":"Thomas","family":"Switzer","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-8801","authenticated-orcid":false,"given":"Animesh","family":"Tandon","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-2382","authenticated-orcid":false,"given":"Willem","family":"van den Brink","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-8436","authenticated-orcid":false,"given":"Srinivasan","family":"Vairavan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-0327","authenticated-orcid":false,"given":"Benjamin","family":"Vandendriessche","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-1253","authenticated-orcid":false,"given":"Bernard","family":"Vrijens","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-0183","authenticated-orcid":false,"given":"Jennifer C.","family":"Goldsack","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"1322_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000514730","volume":"5","author":"JC Goldsack","year":"2021","unstructured":"Goldsack, J. C., Dowling, A. V., Samuelson, D., Patrick-Lake, B. & Clay, I. Evaluation, acceptance, and qualification of digital measures: from proof of concept to endpoint. Digit. Biomark. 5, 53\u201364 (2021).","journal-title":"Digit. Biomark."},{"key":"1322_CR2","unstructured":"Taguibao, C. Celebrating the fourth anniversary of the Library of Digital Endpoints! Digital Medicine Society (DiMe) https:\/\/dimesociety.org\/celebrating-the-fourth-anniversary-of-the-library-of-digital-endpoints\/ (2023)."},{"key":"1322_CR3","unstructured":"Bellerophon. A study to assess pulsed inhaled nitric oxide in subjects with pulmonary fibrosis at risk for pulmonary hypertension (REBUILD). Clinical Trials https:\/\/clinicaltrials.gov\/study\/NCT03267108 (2023)."},{"key":"1322_CR4","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/s41591-023-02459-5","volume":"29","author":"L Servais","year":"2023","unstructured":"Servais, L. et al. First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD. Nat. Med. 29, 2391\u20132392 (2023).","journal-title":"Nat. Med."},{"key":"1322_CR5","unstructured":"U.S. Food and Drug Administration. Medical Device Development Tool (MDDT) summary of evidence and basis of qualification Apple atrial fibrillation history feature. U.S. Food and Drug Administration https:\/\/www.fda.gov\/media\/178230\/download (2024)."},{"key":"1322_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-00318-y","volume":"3","author":"RC Li","year":"2020","unstructured":"Li, R. C., Asch, S. M. & Shah, N. H. Developing a delivery science for artificial intelligence in healthcare. NPJ Digit. Med. 3, 107 (2020).","journal-title":"NPJ Digit. Med."},{"key":"1322_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-022-00557-1","volume":"5","author":"JS Marwaha","year":"2022","unstructured":"Marwaha, J. S., Landman, A. B., Brat, G. A., Dunn, T. & Gordon, W. J. Deploying digital health tools within large, complex health systems: key considerations for adoption and implementation. NPJ Digit. Med. 5, 13 (2022).","journal-title":"NPJ Digit. Med."},{"key":"1322_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-0260-4","volume":"3","author":"JC Goldsack","year":"2020","unstructured":"Goldsack, J. C. et al. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs). NPJ Digit. Med. 3, 55 (2020).","journal-title":"NPJ Digit. Med."},{"key":"1322_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/d41573-020-00168-z","volume":"20","author":"V Mantua","year":"2021","unstructured":"Mantua, V., Arango, C., Balabanov, P. & Butlen-Ducuing, F. Digital health technologies in clinical trials for central nervous system drugs: an EU regulatory perspective. Nat. Rev. Drug Discov. 20, 83\u201384 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1322_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-023-00790-2","volume":"6","author":"S Colloud","year":"2023","unstructured":"Colloud, S. et al. Evolving regulatory perspectives on digital health technologies for medicinal product development. NPJ Digit. Med. 6, 56 (2023).","journal-title":"NPJ Digit. Med."},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.3233\/JPD-202416","volume":"11","author":"L Sacks","year":"2021","unstructured":"Sacks, L. & Kunkoski, E. Digital health technology to measure drug efficacy in clinical trials for Parkinson\u2019s disease: a regulatory perspective. J. Parkinsons Dis. 11, S111\u2013S115 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"1322_CR12","unstructured":"Digital Medicine Society (DiMe). Resources in action. Digital Medicine Society (DiMe) https:\/\/dimesociety.org\/resources-in-action\/ (2022)."},{"key":"1322_CR13","unstructured":"Center for Drug Evaluation & Research. Digital Health Technologies (DHTs) for drug development. U.S. Food and Drug Administration https:\/\/www.fda.gov\/science-research\/science-and-research-special-topics\/digital-health-technologies-dhts-drug-development (2023)."},{"key":"1322_CR14","unstructured":"American Medical Association. Future of health- commercial payer coverage for digital medicine codes. American Medical Association https:\/\/www.ama-assn.org\/system\/files\/issue-brief-commercial-payer-coverage-digital-care.pdf (2023)."},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"e35684","DOI":"10.2196\/35684","volume":"10","author":"HS Kang","year":"2022","unstructured":"Kang, H. S. & Exworthy, M. Wearing the future-wearables to empower users to take greater responsibility for their health and care: scoping review. JMIR mHealth uHealth 10, e35684 (2022).","journal-title":"JMIR mHealth uHealth"},{"key":"1322_CR16","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.mayocp.2023.05.003","volume":"98","author":"D Adedinsewo","year":"2023","unstructured":"Adedinsewo, D. et al. Health disparities, clinical trials, and the digital divide. Mayo Clin. Proc. 98, 1875\u20131887 (2023).","journal-title":"Mayo Clin. Proc."},{"key":"1322_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000517885","volume":"5","author":"M Landers","year":"2021","unstructured":"Landers, M., Dorsey, R. & Saria, S. Digital endpoints: definition, benefits, and current barriers in accelerating development and adoption. Digit. Biomark. 5, 216\u2013223 (2021).","journal-title":"Digit. Biomark."},{"key":"1322_CR18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41531-023-00497-x","volume":"9","author":"JL Adams","year":"2023","unstructured":"Adams, J. L. et al. Using a smartwatch and smartphone to assess early Parkinson\u2019s disease in the WATCH-PD study. NPJ Parkinson\u2019s Dis. 9, 64 (2023).","journal-title":"NPJ Parkinson\u2019s Dis."},{"key":"1322_CR19","unstructured":"U.S. Food and Drug Administration. Class 2 device recall. U.S. Food and Drug Administration https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfres\/res.cfm?id=43539 (2006)."},{"key":"1322_CR20","unstructured":"Center for Drug Evaluation & Research. Digital health technologies for remote data acquisition in clinical investigations. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/digital-health-technologies-remote-data-acquisition-clinical-investigations (2023)."},{"key":"1322_CR21","doi-asserted-by":"publisher","first-page":"e57628","DOI":"10.2196\/57628","volume":"26","author":"A Tandon","year":"2024","unstructured":"Tandon, A. et al. Human Factors, Human-Centered Design, and Usability of Sensor-Based Digital Health Technologies: Scoping Review. J. Med. Internet Res. 26, e57628 (2024).","journal-title":"J. Med. Internet Res."},{"key":"1322_CR22","unstructured":"Center for Devices & Radiological Health. General wellness: Policy for low risk devices\u2014guidance for industry and FDA staff. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/general-wellness-policy-low-risk-devices (2019)."},{"key":"1322_CR23","unstructured":"U.S Food and Drug Administration. Premarket approval (PMA). U.S Food and Drug Administration https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpma\/pma.cfm?id=P160048S026 (2023)."},{"key":"1322_CR24","unstructured":"Center for Devices & Radiological Health. Ingestible telemetric gastrointestinal capsule imaging system - final class II special controls guidance document for industry and FDA. U.S. Food and Drug Administration https:\/\/www.fda.gov\/medical-devices\/guidance-documents-medical-devices-and-radiation-emitting-products\/ingestible-telemetric-gastrointestinal-capsule-imaging-system-final-class-ii-special-controls (2021)."},{"key":"1322_CR25","unstructured":"U.S. Food and Drug Administration. Device classification under section 513(f)(2)(De Novo). U.S. Food and Drug Administration https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/denovo.cfm?id=DEN200011 (2023)."},{"key":"1322_CR26","unstructured":"U.S. Food and Drug Administration. 510(k) premarket notification. U.S. Food and Drug Administration https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K150557 (2015)."},{"key":"1322_CR27","unstructured":"Center for Devices & Radiological Health. Applying human factors and usability engineering to medical devices. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/applying-human-factors-and-usability-engineering-medical-devices (2016)."},{"key":"1322_CR28","unstructured":"U. S Food and Drug Administration. Human factors studies and related clinical study considerations in combination product design and development- draft guidance for industry and FDA staff. U.S Food and Drug Administration https:\/\/www.fda.gov\/media\/96018\/download (2016)."},{"key":"1322_CR29","unstructured":"Center for Drug Evaluation & Research. Comparative analyses and related comparative use human factors studies for a drug-device combination product submitted in an ANDA: Draft guidance for industry. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/comparative-analyses-and-related-comparative-use-human-factors-studies-drug-device-combination (2017)."},{"key":"1322_CR30","unstructured":"European Medicines Agency. Quality documentation for medicinal products when used with a medical device\u2014scientific guideline. European Medicines Agency https:\/\/www.ema.europa.eu\/en\/quality-documentation-medicinal-products-when-used-medical-device-scientific-guideline (2022)."},{"key":"1322_CR31","unstructured":"Department of Health and Social Care. Guidance on applying human factors and usability engineering to medical devices including drug-device combination products in Great Britain. Medicines, Healthcare products Regulatory Agency https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/970563\/Human-Factors_Medical-Devices_v2.0.pdf (2021)."},{"key":"1322_CR32","unstructured":"National Medical Products Association (NMPA). Guiding principles for technical review of human factors design of medical devices [DiMe, Trans.]. Digital Medicine Society (DiMe) https:\/\/datacc.dimesociety.org\/wp-content\/uploads\/2023\/09\/NMPA-Human-Factors-Guidance-English-Translation-FINAL.pdf (2023)."},{"key":"1322_CR33","unstructured":"The European Parliament and the Council of the European Union. Regulation\u20142017\/745\u2014EN\u2014medical device regulation. EUR-Lex https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32017R0745 (2017)."},{"key":"1322_CR34","unstructured":"Center for Devices & Radiological Health. Purpose and content of use-related risk analyses for drugs, biological products, and combination products. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/purpose-and-content-use-related-risk-analyses-drugs-biological-products-and-combination-products (2024)."},{"key":"1322_CR35","unstructured":"International Organization for Standardization. IEC 62366-1:2015. ISO https:\/\/www.iso.org\/standard\/63179.html (2021)."},{"key":"1322_CR36","unstructured":"International Organization for Standardization. IEC\/TR 62366-2:2016. ISO https:\/\/www.iso.org\/standard\/69126.html (2024)."},{"key":"1322_CR37","unstructured":"International Organization for Standardization. ISO 9241-210:2019. ISO https:\/\/www.iso.org\/standard\/77520.html (2019)."},{"key":"1322_CR38","unstructured":"International Organization for Standardization. ISO 20282-1:2006. ISO https:\/\/www.iso.org\/standard\/34122.html (2020)."},{"key":"1322_CR39","unstructured":"International Organization for Standardization. ISO\/TS 20282-2:2013. ISO https:\/\/www.iso.org\/standard\/62733.html (2024)."},{"key":"1322_CR40","unstructured":"Digital Medicine Society (DiMe). Library of Human Factors Resources for Digital Health Technologies. DATAcc by DiMe https:\/\/datacc.dimesociety.org\/resources\/interactive-index-of-human-factors-resources-for-digital-health-technologies-dhts-2\/ (2023)."},{"key":"1322_CR41","unstructured":"International Organization for Standardization. ISO 14971:2019. ISO https:\/\/www.iso.org\/standard\/72704.html (2019)."},{"key":"1322_CR42","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/jamia\/ocad066","volume":"30","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Missing data matter: an empirical evaluation of the impacts of missing EHR data in comparative effectiveness research. J. Am. Med. Inform. Assoc. 30, 1246\u20131256 (2023).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"1322_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ccell.2021.07.019","volume":"39","author":"C Flora","year":"2021","unstructured":"Flora, C. et al. High-frequency temperature monitoring for early detection of febrile adverse events in patients with cancer. Cancer Cell 39, 1167\u20131168 (2021).","journal-title":"Cancer Cell"},{"key":"1322_CR44","unstructured":"Office of Regulatory Affairs. Design controls. U.S. Food and Drug Administration https:\/\/www.fda.gov\/inspections-compliance-enforcement-and-criminal-investigations\/inspection-guides\/design-controls (2023)."},{"key":"1322_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3398","author":"JP Bakker","year":"2024","unstructured":"Bakker, J. P. et al. Regulatory pathways for qualification and acceptance of digital health technology-derived clinical trial endpoints: considerations for sponsors. Clin. Pharmacol. Ther. https:\/\/doi.org\/10.1002\/cpt.3398 (2024).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1322_CR46","doi-asserted-by":"publisher","first-page":"E85","DOI":"10.5888\/pcd11.130262","volume":"11","author":"SE Schaefer","year":"2014","unstructured":"Schaefer, S. E., Van Loan, M. & German, J. B. A feasibility study of wearable activity monitors for pre-adolescent school-age children. Prev. Chronic Dis. 11, E85 (2014).","journal-title":"Prev. Chronic Dis."},{"key":"1322_CR47","doi-asserted-by":"publisher","DOI":"10.2307\/249008","author":"FD Davis","year":"1989","unstructured":"Davis, F. D. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. https:\/\/doi.org\/10.2307\/249008 (1989).","journal-title":"MIS Q."},{"key":"1322_CR48","doi-asserted-by":"publisher","first-page":"103315","DOI":"10.1016\/j.jbi.2019.103315","volume":"100","author":"A Shachak","year":"2019","unstructured":"Shachak, A., Kuziemsky, C. & Petersen, C. Beyond TAM and UTAUT: future directions for HIT implementation research. J. Biomed. Inform. 100, 103315 (2019).","journal-title":"J. Biomed. Inform."},{"key":"1322_CR49","doi-asserted-by":"publisher","unstructured":"Virzi, R. A. Refining the test phase of usability evaluation: how many subjects is enough? Hum. Factors https:\/\/doi.org\/10.1177\/001872089203400407 (1992).","DOI":"10.1177\/001872089203400407"},{"key":"1322_CR50","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/001872089403600215","volume":"36","author":"JR Lewis","year":"1994","unstructured":"Lewis, J. R. Sample sizes for usability studies: additional considerations. Hum. Factors 36, 368\u2013378 (1994).","journal-title":"Hum. Factors"},{"key":"1322_CR51","unstructured":"Digital Medicine Society (DiMe). DATAcc by DiMe Resources. DATAcc by DiMe https:\/\/datacc.dimesociety.org\/resources\/ (2024)."},{"key":"1322_CR52","doi-asserted-by":"publisher","first-page":"e35693","DOI":"10.2196\/35693","volume":"9","author":"A Duffy","year":"2022","unstructured":"Duffy, A., Christie, G. J. & Moreno, S. The challenges toward real-world implementation of digital health design approaches: narrative review. JMIR Hum. Factors 9, e35693 (2022).","journal-title":"JMIR Hum. Factors"},{"key":"1322_CR53","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1177\/1932296818804802","volume":"12","author":"SS Pillalamarri","year":"2018","unstructured":"Pillalamarri, S. S., Huyett, L. M. & Abdel-Malek, A. Novel bluetooth-enabled tubeless insulin pump: a user experience design approach for a connected digital diabetes management platform. J. Diabetes Sci. Technol. 12, 1132\u20131142 (2018).","journal-title":"J. Diabetes Sci. Technol."},{"key":"1322_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/head.13772","volume":"60","author":"A Stubberud","year":"2020","unstructured":"Stubberud, A., Tronvik, E., Olsen, A., Gravdahl, G. & Linde, M. Biofeedback treatment app for pediatric migraine: development and usability study. Headache 60, 889\u2013901 (2020).","journal-title":"Headache"},{"key":"1322_CR55","doi-asserted-by":"publisher","first-page":"e26652","DOI":"10.2196\/26652","volume":"24","author":"C Domingos","year":"2022","unstructured":"Domingos, C., Costa, P., Santos, N. C. & P\u00eago, J. M. Usability, acceptability, and satisfaction of a wearable activity tracker in older adults: observational study in a real-life context in northern Portugal. J. Med. Internet Res. 24, e26652 (2022).","journal-title":"J. Med. Internet Res."},{"key":"1322_CR56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.pec.2014.05.027","volume":"96","author":"SJ Shoemaker","year":"2014","unstructured":"Shoemaker, S. J., Wolf, M. S. & Brach, C. Development of the Patient Education Materials Assessment Tool (PEMAT): a new measure of understandability and actionability for print and audiovisual patient information. Patient Educ. Couns. 96, 395\u2013403 (2014).","journal-title":"Patient Educ. Couns."},{"key":"1322_CR57","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326791\/ (National Library of Medicine, 2016)."},{"key":"1322_CR58","unstructured":"FDA-NIH Biomarker Working Group. Glossary. in BEST (Biomarkers, EndpointS, and other Tools) Resource https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK338448\/#IX-C (U.S. Food and Drug Administration and National Institutes of Health, 2021)."},{"key":"1322_CR59","unstructured":"Nielsen, J. Usability 101: Introduction to Usability. Nielsen Norman Group https:\/\/www.nngroup.com\/articles\/usability-101-introduction-to-usability\/ (2012)."},{"key":"1322_CR60","unstructured":"U.S. Food and Drug Administration. Glossary of terms on clinical trials for patient engagement advisory committee meeting. U.S. Food and Drug Administration https:\/\/fda.report\/media\/108378\/Clinical-Trail-Glossary-Terms.pdf (2017)."},{"key":"1322_CR61","unstructured":"Center for Devices & Radiological Health. General\/specific intended use\u2013guidance for industry. U.S. Food and Drug Administration https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/generalspecific-intended-use-guidance-industry (2020)."},{"key":"1322_CR62","unstructured":"International Organization for Standardization. ISO 13485:2016. ISO https:\/\/www.iso.org\/standard\/59752.html (2020)."},{"key":"1322_CR63","first-page":"467","volume":"216","author":"R Schnall","year":"2015","unstructured":"Schnall, R., Higgins, T., Brown, W., Carballo-Dieguez, A. & Bakken, S. Trust, perceived risk, perceived ease of use and perceived usefulness as factors related to mHealth technology use. Stud. Health Technol. Inform. 216, 467 (2015).","journal-title":"Stud. Health Technol. Inform."},{"key":"1322_CR64","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0733464815624151","volume":"36","author":"KC Preusse","year":"2017","unstructured":"Preusse, K. C., Mitzner, T. L., Fausset, C. B. & Rogers, W. A. Older adults\u2019 acceptance of activity trackers. J. Appl. Gerontol. 36, 127\u2013155 (2017).","journal-title":"J. Appl. Gerontol."},{"key":"1322_CR65","doi-asserted-by":"crossref","unstructured":"Nielsen, J. Usability Inspection Methods Nielsen Norman Group https:\/\/www.nngroup.com\/books\/usability-inspection-methods\/ (John Wiley & Sons, 1994).","DOI":"10.1145\/259963.260531"},{"key":"1322_CR66","unstructured":"IVD Clinical Evidence Working Group. Framework for developing clinical evidence for regulatory and coverage assessments in in vitro diagnostics (IVDs). MDIC https:\/\/mdic.org\/resource\/framework-for-developing-clinical-evidence-for-regulatory-and-coverage-assessments-in-in-vitro-diagnostics-ivds\/ (2019)."},{"key":"1322_CR67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1177\/0272989X9101100203","volume":"11","author":"DG Fryback","year":"1991","unstructured":"Fryback, D. G. & Thornbury, J. R. The efficacy of diagnostic imaging. Med. Decis. Mak. 11, 88\u201394 (1991).","journal-title":"Med. Decis. Mak."},{"key":"1322_CR68","unstructured":"Haddow, J. E., Palomaki, G. E., Haddow, J. & Palomaki, G. E. ACCE: a model process for evaluating data on emerging genetic tests. https:\/\/www.scienceopen.com\/document?vid=397ab49d-0b83-45cc-9ad0-c45b20c833e6 (2003)."},{"key":"1322_CR69","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. An Evidence Framework for Genetic Testing https:\/\/doi.org\/10.17226\/24632 (The National Academies Press, 2017).","DOI":"10.17226\/24632"},{"key":"1322_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-12393-1","volume":"22","author":"SH Henni","year":"2022","unstructured":"Henni, S. H., Maurud, S., Fuglerud, K. S. & Moen, A. The experiences, needs and barriers of people with impairments related to usability and accessibility of digital health solutions, levels of involvement in the design process and strategies for participatory and universal design: a scoping review. BMC Public Health 22, 35 (2022).","journal-title":"BMC Public Health"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01322-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01322-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01322-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T06:08:12Z","timestamp":1737698892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-024-01322-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1038\/s41746-024-01322-2","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.B. is a former employee of Philips and Signifier Medical Technologies and holds company stock or stock options, and reports consulting income from Apnimed and Koneksa Health. R.B. is an employee of Regeneron Pharmaceuticals Inc. and holds company stock or stock options. B.C. is an employee of Genentech and holds company stock. C.C. is an employee of Stel Life Inc. C.C.G. is an employee of ActiGraph LLC. B.H. is a former employee of Johnson & Johnson Innovative Medicine and holds company stock or stock options. N.H.M. is an employee of Exponent Inc. and holds company stock or stock options. E.S.I. is an employee of Koneksa health and may own company stock. N.V.M. is an employee of Johnson & Johnson Innovative Medicine and holds company stocks or stock options. S.Mo. is an employee of Sysnav Healthcare. O.P. is an employee of AARDEX Group. E.S. is a member of the NPJ Digital Medicine editorial board. T.S. is an employee of Genentech and owner of shares of Roche stock. A.T. is a paid consultant for Synergen Health Technologies; Siemens Healthineers; Gabi Smartcare; and Medtronic (relationship is concluded). S.V. is an employee of Johnson & Johnson Innovative Medicine and holds company stock or stock options. B.Va. is a former employee of Byteflies and holds company stock or stock options. BVr is an employee of AARDEX Group and holds company stock or stock options. The remaining authors declare no competing interests: J.C., S.Mc., S.P., M.S., W.vd.B., J.C.G.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}